Patent
   D425614
Priority
Apr 16 1999
Filed
Apr 16 1999
Issued
May 23 2000
Expiry
May 23 2014
Assg.orig
Entity
unknown
11
20
n/a
The ornamental design for a tablet, as shown and described.

FIG. 1 is a top plan view of a tablet showing our new design;

FIG. 2 is a bottom plan view thereof;

FIG. 3 is a front elevational view thereof;

FIG. 4 is a rear elevational view thereof;

FIG. 5 is a left side elevational view thereof;

FIG. 6 is a right side elevational view thereof;

FIG. 7 is a top perspective view thereof, on an enlarged scale; and,

FIG. 8 is a bottom perspective view thereof, on an enlarged scale.

Katdare, Ashok V., Chen, Tzyy-Show H., Nyairo, Thomas G.

Patent Priority Assignee Title
D564086, May 30 2005 Takeda Nycomed AS Tablet
D671636, Apr 23 2010 DAIICHI SANKYO COMPANY, LIMITED Pharmaceutical tablet
D741990, Jul 30 2013 RB HEALTH US LLC Tablet
D755949, Jul 30 2013 RB HEALTH US LLC Tablet
D787042, Apr 28 2015 Celgene Corporation Pharmaceutical tablet
D787043, Jun 23 2015 Celgene Corporation Pharmaceutical tablet
D813372, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D835257, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D835258, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D858741, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D947358, Mar 19 2019 Novo Nordisk A/S Pill
Patent Priority Assignee Title
2687367,
4693886, Apr 22 1985 ALZA Corporation Osmotic device with inert core
4851228, Jun 20 1984 MERCK & CO , INC , A CORP OF NJ Multiparticulate controlled porosity osmotic
5424074, Jun 20 1989 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition for potassium supplementation
5427798, Aug 14 1992 SMITHKLINE BEECHAM CORPORATION, A PENNSYLVANIA CORPORATION Controlled sustained release tablets containing bupropion
5512299, Mar 30 1992 ALZA Corporation Method of treating oral inflammatory disease
5770225, Apr 28 1989 McNeil-PPC, Inc. Process of preparing a subcoated simulated capsule-like medicament
5824338, Aug 19 1996 L. PERRIGO COMPANY Caplet and gelatin covering therefor
216307,
D258091, Aug 31 1978 Marion Laboratories, Inc. Pharmaceutical tablet
D301764, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D302051, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D316914, Aug 01 1989 MERRELL DOW PHARMACEUTICALS LTD Tablet
D359554, Dec 02 1991 The Procter & Gamble Company Tablet
D375157, Dec 22 1992 Merck Sharp & Dohme Corp Tablet
D379223, Sep 13 1995 Merck Sharp & Dohme Corp Pharmaceutical tablet
D380825, Oct 31 1994 Merck Sharp & Dohme Corp Pharmaceutical tablet
D400672, Mar 21 1996 Merck Sharp & Dohme Corp Pharmaceutical tablet
D403396, Nov 28 1996 Astra Aktiebolag Tablet
56478,
///////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Apr 16 1999Merck & Co., Inc.(assignment on the face of the patent)
Sep 08 1999KATDARE, ASHOK V MERCK & CO , INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0106340261 pdf
Sep 10 1999CHEN, TZYY-SHOW H MERCK & CO , INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0106340276 pdf
Sep 10 1999NYAIRO, THOMAS G MERCK & CO , INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0106340276 pdf
Nov 02 2009MERCK & CO , INC Merck Sharp & Dohme CorpCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0238700001 pdf
Apr 26 2012Merck Sharp & Dohme CorpSchering CorporationMERGER SEE DOCUMENT FOR DETAILS 0288500515 pdf
May 02 2012Schering CorporationMerck Sharp & Dohme CorpCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0288660511 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule